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822-6 Chlamydia Pneumoniaelnfection and Eight-Year 
Outcome in 695 Patients Undergoing Coronary 
Angiography 
kinase (CK, U/g wet wt) and the reduction of MTT to insoluble formazan dye (mM/g wet 
wt) were measured. 
Stephen K. Glen, Jonathan Welch, Andrew Flapan. Sheena Sutherland, Royal Infirmary 
of Edinburgh, Edinburgh, United Kingdom 
Background: The role of Chlamydia pneumoniae in the development of coronary artery 
disease remains uncertain and while pathological studies suggest high levels of antigen 
in atherosclerotic vessels, epidemiological evidence is less convincing. This study eram- 
ines the relation between Cpneumoniae infection determined by IgG and IgA levels and 
the Severity of coronary artery disease in patients undergoing coronary angiography, and 
subsequent all cause mortality in an eight year follow-up period. 
Methods: Blood samples from 895 patients who underwent coronary angiography in 
1992 were analysed for IgG and IgA antibodies to Cpneumoniae, and tested for Cpneu- 
moniaeDNA using polymerase chain reactlon (PCR). Follow-up mortality statistics were 
provided by the General Register Office for Scotland and included analysis of death cer- 
tificates 
Results: The risk of angiographic crxcmary artery disease was higher in patients with an 
IgG titre 2 1:128 (odds ratio 1.63,95% Cl 1.19.2.25), and IgA titrez 1:64 (odds ratio 2.30, 
95% Cl 1.54-3.42). There was no significant difference in IgG or IgA titres between the 
patients with stable angina and those presenting with unstable angina. The antibody 
response did not predict all cause mortality or cardiovascular outcome after 6 years of 
follow up. CpneumoniaeDNA was not directly detected in any patient using PCR despite 
using a variety of primers. 
Conclusions: Antibody responses to Cpneumoniae are cwnm~n and do not indicate an 
adverse prognosis. Although there was an association with angiographically demon- 
strated coronary disease, this did not translate into an effect on all-cause or cardiovascu- 
lar mortality. 
Results: The protection conferred by ischemic preconditioning with 5min ischemiti5min 
reoxygenation (CK=1.5*0.1 and MTT=l68.9+6.7 vs. CK=3.1*0.1 and MTT=l04.2*5.9 in 
the SllR group; peO.05) was abolished by glibenclamide at all doses investigated 
(CK=2.&0.1, 3.1*0.1, 2.9+0.1 and 2.7kO.i; MlT=l00.7~7.5, 108+7.0, 102.4*4.7 and 
6&O&9 at 0.1, I, 3 and IQIM respectively; p=NS vs. SllR in all instances). By contrast, 
gliclazide at equipotent doses to that of glibenclamide abolished protection only at the 
dose of lOO@l (CK=2.6*0.2 and MTT=84.0+6.3) but not at I,10 or 3OpM (CK=2.0+0.1, 
2.5iO.i and 2.8eO.l; MTT=l47.7*4.7, 134.7e6.1 and 125.7r4.0 respectively; ~~0.05 vs. 
SllR in all instances). Glibenclamide used at dose of 1pM abolished the protection of the 
mttoKATp channel opener diazoxide (100pM) (from CK=l.9+0.2 and MTT=l61.9+15.0 to 
CK=2.9*0.2 and MTT=75.9+10.9; ~~0.05) but not that of the PKC activator PMA (1 CM) 
(from CK=l.6iO.l and MTT=l48.0*13.9 to CK=l.9t0.3 and MTT= 160+1&O; p=NS) or 
the p38MAPK activator anisomycin (1nM) (from CK=l.7*0.1 and MTT=l53.1*16.5 to 
CK=l.8r0.2 and MTT=l53.9*22.7; p=NS).Conclusion: The loss of the cardioprotection 
of ischemic preconditioning by sulfonylureas is dependent on type and dose of agent. 
The abolition of protection by glibenclamide is due to specific blockade of mitoK, chan- 
nels without affecting other elements of the signal transduction pathway, so that in the 
presence of glibenclamide protection can still be elicited by activation of PKC and 
p38MAPK. 
1123-108 TNFa and IL-6 Release During Primary Percutaneous 
Coronary Intervention for Acute Mvocardial Infarction Is 
Related io Coronary Collateral Flow 
Robv D. Rakhit. Christian Seiler, Kerstin Wustmann, Stephan Zbinden, Stephan 
Windecker, Bernhard Meier, Franz Eberli, Swiss Cardiovascular Center. Bern, 
Background: Tumour necrosis factor-alpha (TNF-a) and Interleukind (IL-6) increase dur- 
ing acute myocardial infarction (AMI). We tested the hypothesis that there was an associ- 
ation between TNF-a, IL-6 release and measured coronary collateral flow in patients 
undergoing primary percutaneous coronary intervention (PCI) for acute myocardial inf- 
arction (AMI). 
Methods: 12 patients with AMI and complete occlusion of the infarct related artery under- 
went primarv PCI within 12 hours of svmotom onset. DoDDlet-derived collateral flow 
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1123-106 Recurrence of ST Elevation After Early Reperfusion as a 
Marker of Prognosis in ST Elevation Infarction 
Per Johanson Cynthia L. Green, Karen Loeffler, Kathleen M. Trollinger, Suzanne W. 
Crater, Mitchell W. Krucoff, Duke University Medical Center, Durham, NC 
Background: Continuous ST-monitoring can non-invasively quantify not only rapidity 
and extent, but also stabikty in restoration of myocardial perfusion during ST-elevation 
infarction (STEMI). We examined whether signs of reocclusion reversed prognostic gain 
won by early repelfusion and added information. Methods: In a meta-analysis of 11 IO 
patients with STEMI (from DUCCSP, TAMIS, GUSTOl,-3 and -5, PARADIGM, PRIME 
and IMPACT-AMI), monitored with continuous digital 12.lead ECG for 24 hours, were 
divided according to 1) Early reperfusion: ~50% ST-recovery within 60 minutes or not; 
and 2) Reocclusive signs: recurrence of ST-elevation (RO) or not. ECG-data was ana- 
lyzed blindly. RO was defined as ST re-elevation of ~15OuV for >lminute. Findings were 
correlated to in-hospital outcome (mortality, teinfarction and new heart-failure). Results 
RO contributed significantly to information on the combined endpoint in both the early- 
(p=O.O2), and late- (~~0.02) reperfusion-groups. For information on mortality there was a 
trend in the same direction (table). 
Conclusion : Simple qualitative assessment of RO by continuous ST-monitoring can be 
used to improve risk-stratification and adds information to ST-recovery analyses. 
Group: x50%, RO- >=50%, RO+ <50%, RO- <50%, RO+ 
N= 329 198 326 257 
Comb. Endp. % * 17.6 26.3 21.2 29.2 
Mortality, % *+ 1.5 5.0 2.4 4.3 
* p, trend=0.005; ** p, trend=0.07 
1123-107 Blockade of Preconditioning by Sulfonylureas Can Be 
Overcome by Activation of PKC and p36MAPK 
. 
index (CFI) was measured during first balloon inflation. TNF-a, IL-6. together with Creat- 
ine Kinase (CK). Creatine Kinase MB Fraction fCK-MB) were measured from venous 
I  
plasma samples serially every 6 hours for 24 hours. Area at risk was determined off-line 
by coronary arieriography. Ejection fraction was measured using biplane left ventricular 
angiography. 
Results: In all patients TNF-a (peak 4.4 * 0.5 pg/ml, normal ~2) and IL-6 (35.5 * 3.0 pg/ 
ml, normal c 5) increased. No minlmal threshold of myocardial necrosis for cytokine 
expression could be detected. Maximal CK release varied between 569 and 6276 u/L 
and area at risk varied between 7 and 47% of myocardium. Peak TNF-a and IL-6 release 
was independent of CK or CKMB release. TNF-a and IL-6 release was also independent 
of time to repelfusion, area at risk or ejection fraction. However, using univariate regres- 
sion analysis peak TNF-a inversely correlated with CFI (r=0.67. p=O.O17) whereas IL-6 
positively correlated with CFI (r=0.76. p=O.O04). 
Conclusions: During AMI TNF-a and IL-6 levels are increased independent of infarct size 
suggesting that cytokines are increased predominantly by a systemic inflammatory 
response. Coronary collateral flow seems to modify the expression of cytokines suggest- 
ing a different role for specific cytokines in ischemic and reperfused myocardium. 
1123-109 Discrepancies in Cardiac Function Corrected by 
Revascularization in Those With Severe lschemic 
Functional Disability 
David J. Wriqht, Simon G. Williams, Rhona Obrien. Bing Tzeng, Lip 8. Tan, Leeds 
General Infirmary, Leeds, United Kingdom 
A peak oxygen consumption (VO2) below 14 ml/kg/min in patients being assessed for 
cardiac transplantation, does not confer a severe reduction in cardiac pump perfor- 
mance. A similar disparate relationship has been reported for patients with ischaemic 
heart disease and we tested the hypothesis that this could be normalized with revascu- 
larisation. 
We performed cardiopulmonary exercise tests with haemodynamic measurements, one 
month before and three months after successful CABG in 67 consecutive patients. We 
divided the patients according to whether their pre-operative peak V02 was above or 
below 14. 
19 patients had a pre-operative peak V02 < 14. Following CABG the correlation coeffi- 
cient for this group between peak V02 and peak cardiac output (CO) increased from r = 
0.5 (p = NS) to r = 0.79 (p < 0.005). The regression equation changed from V02 = 
0.42CO + 8.5, to V02 = 1.24CO + 3.6, a significant change when assessed using linear 
regression analysis (p 14. Following CABG the correlation coefficient between peak V02 
and peak cardiac output remained relatively constant r = 0.55 and r = 0.58. both p c 
0.005. The regression equation changed from V02 = 1.04CO + 6.9, to V02 = 1.06CO + 
8.2, a non-significant change when assessed using linear regression analysis. 
In patients with ischaemic heart disease and severe functional disability, the disparate 
relationship between cardiac pump performance and peak V02 is corrected followina 
Mahmoud Loubani, Alan G. Fowler, Nicholas B. Standen, Manuel Gafirianes, Glenfield 
Hospital, Leicester, United Kingdom 
Background: Cardioprotection by ischemic preconditioning is lost in the presence of sul- 
fonylureas probably due to blockade of mitol$,, channels. Here we investigate the 
surgical reiascularisation. The relationship is constant throughout in a control group with- 
out such severe functional impairment. 
impact of two sulfonylureas glibenclamide and gliclazide on the protection and whether 
this could be overcome by activation of PKC and p38MAPK. 
Methods: Right atrial appendages from patients undergoing elective cardiac surgery 
were subjected to 90min of simulated ischemia followed by 120min reoxygenation @I/R). 
At the end of each protocol (n=8 specimens/group in each study), the leakage of creatine 
